You have 9 free searches left this month | for more free features.

Arsenic trioxide

Showing 1 - 25 of 264

STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS

Pediatric Cancer, Li-Fraumeni Syndrome, p53 Mutations Trial in Guangzhou (Arsenic trioxide)

Not yet recruiting
  • Pediatric Cancer
  • +2 more
  • Arsenic trioxide
  • Guangzhou, Guangdong, China
    Sun Yat-sen Memorial Hospital, Sun Yat-sen University
Oct 12, 2023

Essential Thrombocythemia, Polycythemia Vera, Primary Myelofibrosis Trial in Buffalo (drug, dietary supplement, other)

Terminated
  • Essential Thrombocythemia
  • +2 more
  • Arsenic Trioxide
  • +3 more
  • Buffalo, New York
    Roswell Park Cancer Institute
Jul 20, 2022

Colorectal Cancer, Metastatic Colorectal Cancer Trial in Almaty (D-isoascorbic Acid (D-VC) With Arsenic Trioxide (ATO),

Recruiting
  • Colorectal Cancer
  • Metastatic Colorectal Cancer
  • D-isoascorbic Acid (D-VC) With Arsenic Trioxide (ATO)
  • FOLFOX/FOLFIRI regimen
  • Almaty, Kazakhstan
    Kazakh Institute of Oncology and Radiology
Feb 8, 2023

Efficacy and Safety Trial in Zhejiang (Arsenic trioxide Tablet +Fuzuloparib Capsules)

Recruiting
  • Efficacy and Safety
  • Arsenic trioxide Tablet +Fuzuloparib Capsules
  • Zhejiang, Hangzhou, China
    Women's Hospital School Of Medicine Zhejiang University
Jan 23, 2022

Acute Promyelocytic Leukemia Trial in United States (SY-2101, Arsenic Trioxide)

Recruiting
  • Acute Promyelocytic Leukemia
  • Birmingham, Alabama
  • +4 more
Jul 12, 2022

Cardiotoxic Medication Use Due to Sodium Arsenite Chloride

Recruiting
  • Adverse Reaction
  • +2 more
  • Sodium arsenite chloride injection
  • Jinan, Shandong, China
  • +1 more
Sep 23, 2023

Promyelocytic Leukemia Trial in Monterrey (Arsenic trioxide, all-trans retinoic acid)

Recruiting
  • Promyelocytic Leukemia
  • Arsenic trioxide
  • all-trans retinoic acid
  • Monterrey, Nuevo Leon, Mexico
    Hopsital Universitario Dr. Jose E. Gonzalez, Centro Universitari
Aug 9, 2022

HIV/AIDS Trial in Guangzhou (Arsenic Trioxide)

Recruiting
  • HIV/AIDS
  • Arsenic Trioxide
  • Guangzhou, Guangdong, China
    Guangzhou 8th People's Hospital
Jul 19, 2021

Neuroblastoma Trial in Guangzhou (Arsenic Trioxide)

Recruiting
  • Neuroblastoma
  • Arsenic Trioxide
  • Guangzhou, Guangdong, China
    Sun Yat-sen Memorial Hospital, Sun Yat-sen University
Jul 29, 2021

Acute Myeloid Leukemia Trial in Xi'an (All-trans retinoic acid, Arsenic Trioxide, Realgar-Indigo naturalis formula)

Recruiting
  • Acute Myeloid Leukemia
  • All-trans retinoic acid
  • +2 more
  • Xi'an, Shaanxi, China
    First Affiliated Hospital of Xi'an Jiaotong University
Mar 23, 2022

Refractory Solid Tumors Trial in Shanghai (Arsenic trioxide)

Recruiting
  • Refractory Solid Tumors
  • Arsenic trioxide
  • Shanghai, China
    Department of Oncology, Ruijin Hospital
May 11, 2021

Acute Promyelocytic Leukemia Trial in Canada, United States (Tretinoin and Arsenic Trioxide)

Completed
  • Acute Promyelocytic Leukemia
  • Tretinoin and Arsenic Trioxide
  • Los Angeles, California
  • +11 more
Nov 2, 2021

Arsenic Trioxide, Childhood ALL Trial in Guangzhou (Realgar Indigo naturalis formula, Conventional chemo)

Recruiting
  • Arsenic Trioxide
  • Childhood ALL
  • Realgar Indigo naturalis formula
  • Conventional chemotherapy
  • Guangzhou, Guangdong, China
    Sun Yat-sen Memorial Hospital, Sun Yat-sen University
Jan 10, 2023

Arsenic Trioxide, p53 Mutations, Refractory Cancer Trial in Shanghai (Arsenic Trioxide)

Recruiting
  • Arsenic Trioxide
  • +3 more
  • Arsenic Trioxide
  • Shanghai, China
    Department of Medical Oncology, Shanghai Changzheng Hospital
Jan 4, 2021

RWE of 1st Line Treatment With ATO/ATRA for Adult APL

Recruiting
  • Promyelocytic Leukemia, Adult Acute
  • Evaluation of first line treatment with ATO/ATRA outcome
  • Caba, Argentina
  • +1 more
Nov 9, 2021

Acute Myeloid Leukemia, Relapsed/Refractory Acute Myeloid Leukemia Trial in Aurora (Cyclophosphamide)

Completed
  • Acute Myeloid Leukemia
  • Relapsed/Refractory Acute Myeloid Leukemia
  • Aurora, Colorado
    University of Colorado Denver
Apr 28, 2021

Lung Cancer, Cancer of Lung, Pulmonary Cancer Trial in Atlanta (Arsenic Trioxide)

Completed
  • Lung Cancer
  • +4 more
  • Arsenic Trioxide
  • Atlanta, Georgia
    Emory University Winship Cancer Institute
Feb 15, 2021

P53 Mutation, Myeloid Malignancy, MDS Trial in Shanghai (Decitabine, Arsenic Trioxide)

Recruiting
  • P53 Mutation
  • +3 more
  • Shanghai, Shanghai, China
    Hematological department, Shanghai Institute of Hematology, Ruij
Apr 20, 2021

NPMc+ AML Trial in Hong Kong (Oral Arsenic Trioxide Formulation)

Recruiting
  • NPMc+ AML
  • Oral Arsenic Trioxide Formulation
  • Hong Kong, Hong Kong
    The University of Hong Kong
Dec 29, 2020

Acute Promyelocytic Leukemia Trial in Hong Kong (Oral Arsenic Trioxide Formulation)

Recruiting
  • Acute Promyelocytic Leukemia
  • Oral Arsenic Trioxide Formulation
  • Hong Kong, Hong Kong
    The University of Hong Kong
Dec 29, 2020

Arsenic Trioxide in Newly Diagnosed, Low-to-intermediate Risk

Recruiting
  • Acute Promyelocytic Leukemia
  • Arsenic Trioxide
  • Alessandria, Italy
  • +27 more
Dec 31, 2021

Skin Basal Cell Carcinoma Trial (Arsenic Trioxide, Itraconazole, Laboratory Biomarker Analysis)

Withdrawn
  • Skin Basal Cell Carcinoma
  • Arsenic Trioxide
  • +2 more
  • (no location specified)
Oct 20, 2020

Acute Promyelocytic Leukemia Trial in Hong Kong (Oral arsenic Trioxide, ATRA and ascorbic acid)

Recruiting
  • Acute Promyelocytic Leukemia
  • Oral arsenic Trioxide, ATRA and ascorbic acid
  • Hong Kong, N/A = Not Applicable, Hong Kong
    Department of Medicine, the University of Hong Kong, Queen Mary
Nov 3, 2020

Multiple Myeloma and Plasma Cell Tumor Trial in United States (arsenic trioxide)

Terminated
  • Multiple Myeloma and Plasma Cell Neoplasm
  • arsenic trioxide
  • La Jolla, California
  • +5 more
Oct 2, 2020

Leukemia, MDS Trial in Los Angeles (arsenic trioxide, azacitidine)

Terminated
  • Leukemia
  • Myelodysplastic Syndromes
  • Los Angeles, California
    Jonsson Comprehensive Cancer Center at UCLA
Jul 29, 2020